Role of caspase-8 in glioblastoma resistance to TRAIL -induced apoptosis

Journal of Jilin University Medicine Edition

Volumn 37, Issue 4, 2011, Pages 612-616

  Qi, Ling ^a   Yu, Hong Quan ^b   Jin, Hong ^a   Ding, Li Juan ^b   Wen, Na ^a   Tang, Ze Bo ^a   Li, Yun Qian ^b  

^a JILIN MEDICAL COLLEGE   (China)

^b JILIN UNIVERSITY   (China)

Author keywords

Caspase 8; Glioblastoma; Tumor necrosis factor related apoptosis inducing ligand

Indexed keywords

CASPASE 8; DEATH RECEPTOR 4; DEATH RECEPTOR 5; FAS ASSOCIATED DEATH DOMAIN PROTEIN; RECOMBINANT TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; GLIOBLASTOMA; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; TUMOR RESISTANCE; WESTERN BLOTTING;

EID: 80052289146     PISSN: 1671587X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Anita C, Qi L, Mulligan P, et al. TRAIL agonists on clinical trials for cancer therapy: The promises and the challenges[J]. Rev Recent Clin Trials (Online), 2009, 4(1):34-41.
2. Hopkins-Donaldson S, Bodmer JL, Bourloud KB, et al. Loss of caspase-8 expression in highly malignant human neuroblastoma cells correlates with resistance to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis[J]. Cancer Res, 2000,60(16):4315-4319. (Pubitemid 32103601)
3. Li YC, Tzeng CC, Song JH, et al. Genomic alterations in human malignant glioma cells associate with the cell resistance to the combination treatment with tumor necrosis factor-related apoptosis-inducing ligand and chemotherapy[J]. Clin Cancer Res, 2006,12(9):2716-2729.
4. Hanahan D, Weinberg RA. The hallmarks of cancer[J]. Cell, 2000,100(1):57-70.
5. Lefranc F, Facchini V, Kiss R. Proautophagic drugs: a novel means to combat apoptosis-resistant cancers, with a special emphasis on glioblastomas[J]. Oncologist, 2007,12(2):1395-1403.
6. Ball S, Li C, Li PK, et al. The small molecule, LLL12, inhibits STAT3 phosphorylation and induces apoptosis in medulloblastoma and glioblastoma Cells[J]. PLoS One, 2011,6(4):e18820.
7. Stupp R, Warren P, Martin J, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma[J]. N Engl J Med, 2005,352(10):987-996. (Pubitemid 40349501)
8. Sathornsumetee S, Reardon DA, Desjardins A, et al. Molecularly targeted therapy for malignant glioma[J]. Cancer, 2007,110(1):13-24.
9. Bellail AC, Tse MC, Song JH, et al. DR5-mediated DISC controls caspase-8 cleavage and initiation of apoptosis in human glioblastomas[J]. J Cell Mol Med, 2010, 14(6A):1303-1317.
10. Chun HJ, Zheng L, Ahmad M, et al. Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency[J]. Nature, 2002,419(6905):395-399.
11. Hopkins D, Onaldson S, Ziegler A, et al. Silencing of carcinoma cell lines and tumors by DNA methylation[J]. Cell Death Differ, 2003,10(3):356-364.
12. Yang X, Thiele CJ. Targeting the tumor necrosis factor-related apoptosis-inducing ligand path in neuroblastoma[J]. Cancer Lett, 2003,197(1/2):137-143. (Pubitemid 36860003)